tiprankstipranks
Trending News
More News >
Clover Biopharmaceuticals Ltd. (HK:2197)
:2197
Hong Kong Market

Clover Biopharmaceuticals Ltd. (2197) Stock Statistics & Valuation Metrics

Compare
0 Followers

Total Valuation

Clover Biopharmaceuticals Ltd. has a market cap or net worth of HK$337.24M. The enterprise value is HK$1.27B.
Market CapHK$337.24M
Enterprise ValueHK$1.27B

Share Statistics

Clover Biopharmaceuticals Ltd. has 1,297,062,400 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,297,062,400
Owned by Insiders
Owned by Institutions

Financial Efficiency

Clover Biopharmaceuticals Ltd.’s return on equity (ROE) is 0.55 and return on invested capital (ROIC) is 94.29%.
Return on Equity (ROE)0.55
Return on Assets (ROA)-1.11
Return on Invested Capital (ROIC)94.29%
Return on Capital Employed (ROCE)0.87
Revenue Per Employee128.06K
Profits Per Employee-3.01M
Employee Count300
Asset Turnover0.05
Inventory Turnover64.49

Valuation Ratios

The current PE Ratio of Clover Biopharmaceuticals Ltd. is -0.31. Clover Biopharmaceuticals Ltd.’s PEG ratio is 0.01.
PE Ratio-0.31
PS Ratio0.00
PB Ratio-3.77
Price to Fair Value-0.17
Price to FCF-1.40
Price to Operating Cash Flow-1.49
PEG Ratio0.01

Income Statement

In the last 12 months, Clover Biopharmaceuticals Ltd. had revenue of 38.42M and earned -903.43M in profits. Earnings per share was -0.72.
Revenue38.42M
Gross Profit-672.94M
Operating Income-951.21M
Pretax Income-903.43M
Net Income-903.43M
EBITDA-916.54M
Earnings Per Share (EPS)-0.72

Cash Flow

In the last 12 months, operating cash flow was -157.93M and capital expenditures -1.23M, giving a free cash flow of -159.15M billion.
Operating Cash Flow-157.93M
Free Cash Flow-159.15M
Free Cash Flow per Share-0.12

Dividends & Yields

Clover Biopharmaceuticals Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta2.04
52-Week Price Change-29.73%
50-Day Moving Average0.22
200-Day Moving Average0.27
Relative Strength Index (RSI)56.24
Average Volume (3m)1.39M

Important Dates

Clover Biopharmaceuticals Ltd. upcoming earnings date is Aug 20, 2025, TBA Not Confirmed.
Last Earnings DateMar 31, 2025
Next Earnings DateAug 20, 2025
Ex-Dividend Date

Financial Position

Clover Biopharmaceuticals Ltd. as a current ratio of 0.35, with Debt / Equity ratio of -53.04%
Current Ratio0.35
Quick Ratio0.34
Debt to Market Cap0.26
Net Debt to EBITDA0.34
Interest Coverage Ratio-165.25

Taxes

In the past 12 months, Clover Biopharmaceuticals Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Clover Biopharmaceuticals Ltd. EV to EBITDA ratio is 0.03, with an EV/FCF ratio of 0.10.
EV to Sales-0.72
EV to EBITDA0.03
EV to Free Cash Flow0.10
EV to Operating Cash Flow0.10

Balance Sheet

Clover Biopharmaceuticals Ltd. has HK$427.53M in cash and marketable securities with ¥89.64M in debt, giving a net cash position of -HK$337.88M billion.
Cash & Marketable SecuritiesHK$427.53M
Total Debt¥89.64M
Net Cash-HK$337.88M
Net Cash Per Share-HK$0.26
Tangible Book Value Per Share-HK$1.33

Margins

Gross margin is 0.00%, with operating margin of -2475.88%, and net profit margin of -2351.51%.
Gross Margin0.00%
Operating Margin-2475.88%
Pretax Margin-2351.51%
Net Profit Margin-2351.51%
EBITDA Margin-2385.64%
EBIT Margin-2485.33%

Analyst Forecast

The average price target for Clover Biopharmaceuticals Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast-1.73%
EPS Growth Forecast-689.53%

Scores

Smart Score5
AI Score45
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis